Purchase of a Helicos® Genetic Analysis System includes collaboration on the development of targeted resequencing assays CAMBRIDGE, Mass.–Helicos BioSciences Corporation (NASDAQ: HLCS) today announced the sale of a system and a scientific collaboration with Correlagen Diagnostics Inc., a leading provider of genetic tests for disease diagnosis. “We are very excited to have Correlagen as both […]
SEQUENOM to Hold Conference Call Today at 2:00 p.m. Pacific Time SAN DIEGO — SEQUENOM, Inc. (Nasdaq: SQNM – News) today announced the completion of the independent investigation by a special committee of independent directors related to the test data and results for the company’s noninvasive prenatal test for Trisomy 21 (Down syndrome). The independent […]
DENVER–Accelr8 Technology Corporation (NYSE Amex: AXK) announced today that it has concluded a technical development project with Becton, Dickinson and Company (“BD”) (NYSE: BDX – News). Accelr8’s technology met formal testing requirements for identification of a subset of relevant species of bacteria. However, BD advised the Company that it has decided to decline an associated […]
30-Minute Test for Genetic Risk of Thrombosis Improves Time-to-Result Over Previous Molecular Tests SUNNYVALE, Calif. and BEDFORD, Mass. — Cepheid (Nasdaq: CPHD – News) and Instrumentation Laboratory (IL) today announced that Cepheid has received clearance from the U.S. Food & Drug Administration (FDA) to market its Xpert® HemosIL® FII & FV test. The test detects […]
Osmetech plc (‘Osmetech’, OMH.L), the international molecular diagnostics business, announced today that following discussions with Fisher HealthCare, a division of Fisher Scientific Company L.L.C, both companies have mutually agreed to terminate, with immediate effect, their US distribution agreement, which was entered into in March 2009. Osmetech has made the strategic decision to build its own […]
MOUNTAIN VIEW, Calif.–Perlegen Sciences, which develops genetic tests that correlate genetic variation to disease risk and drug response, announced today that its BREVAGen™ breast cancer risk stratification test is now clinically available in select U.S. markets. Perlegen plans to add sales areas to make the test available nationwide over the next few months. Perlegen designed […]
Merck and QIAGEN Collaborate to Accelerate Access to Cervical Cancer Vaccination and Screening in Developing Countries – Major New Collaboration Announced at Clinton Global Initiative Annual Meeting NEW YORK –Merck & Co., Inc. and QIAGEN N.V. today announced their intent to collaborate on a new program to increase access to HPV vaccination and HPV DNA […]
In addition, QIAGEN unveils for the first time its companion diagnostic pipeline, which the Company believes is unmatched in terms of depth and profile VENLO, The Netherlands – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) today announced that it has acquired DxS Ltd (DxS), a privately-held developer and manufacturer of companion diagnostic products headquartered […]
Company to Present at UBS Global Life Sciences Conference on Sept. 23 HUNTINGTON BEACH, California and AMSTERDAM — Agendia, a world leader in molecular cancer diagnostics, today announced the successful closing of a US $23 million series E investment. The financing round was led by an undisclosed family investment firm that provided approximately half of […]
Labor Becker-Olgemoeller Selects Bruker´s MALDI Biotyper as an Integrated Multi-Workstation Solution for Microbial Identification GÖTTINGEN, Germany — At the 61st Annual Meeting of the German Society for Hygiene and Microbiology, Bruker Daltonics announces that Labor Becker-Olgemöller in Munich has installed the Bruker MALDI Biotyper as their next-generation, rapid molecular microbial identification system. One key factor […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
